Background: Treatment for severe systemic infections in heart transplantation is reduction in immunosuppression while treating the infection. An assay that measures adenosine triphosphate production in activated lymphocytes (ImmuKnow ) objectively monitors cellular immunity of transplant recipients. In this study, we used ImmuKnow to adjust immunosuppression in heart transplant recipients with severe systemic infections.
Methods: Heart transplant recipients were followed with ImmuKnow at the time of biopsy and diagnosis of systemic infection. Patients who developed an infection were monitored by ImmuKnow assay with adjustments in immunosuppression based upon the results of the assay. Maintenance immunosuppression was reinstituted when the ImmuKnow increased to >225 ng/mL of ATP.
Results: Two or more ImmuKnow assays were performed in 80 patients. Thirteen patients developed severe systemic infections. ImmuKnow mean value at the time of diagnosis of infection was 109 ± 49.2 ng/mL. Reduction in immunosuppression and treatment of infection resulted in normalization of ImmuKnow level, resolution of infection, and no episodes of rebound rejection.
Conclusion: Heart transplant recipients with severe systemic infections presented with a decreased ImmuKnow , suggesting over immunosuppression. ImmuKnow can be used as an objective measurement in withdrawing immunosuppression in heart transplant recipients with severe systemic infections.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ctr.13809 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Canadian Highly Sensitized Patient Program Report: A 1000 Kidney Transplants Story.
Can J Kidney Health Dis
December 2024
Division of Nephrology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, QC, Canada.
Purpose: Highly sensitized patients (HSPs) with kidney failure have limited access to kidney transplantation and poorer post-transplant outcomes. Prioritizing HSPs in kidney allocation systems and expanding the pool of deceased donors available to them has helped to reduce their wait times for transplant and enhanced post-transplant outcomes. The Canadian HSP Program was established by Canadian Blood Services in collaboration with provincial organ donation and transplantation programs throughout the country to increase transplant opportunities for transplant candidates needing very specific matches from deceased kidney donors.
View Article and Find Full Text PDFIncidence, Prediction, and Prevention of Fractures After Kidney Transplantation: A Systematic Review Protocol.
Can J Kidney Health Dis
December 2024
Department of Medicine, Western University, London, ON, Canada.
Background: Kidney transplant recipients are uniquely exposed to the disordered bone metabolism associated with chronic kidney disease beginning before transplantation followed by chronic corticosteroid use after transplantation. Previous efforts to synthesize the rapidly accruing evidence regarding estimation and management of fracture risk in kidney transplant recipients are outdated and incomplete.
Objective: To synthesize the evidence informing the overall incidence, patient-specific risk prediction, and methods of prevention of fractures in patient living with a kidney transplant.
Self-Management of Kidney Transplant Recipients Research: A Comprehensive Bibliometric Analysis.
J Multidiscip Healthc
December 2024
Department of Nursing, Zhongnan Hospital, Wuhan University, Wuhan, Hubei Province, People's Republic of China.
Objective: This study analyzes research trends in self-management among kidney transplant recipients to inform future directions.
Methods: Bibliometric analysis was performed on 444 English articles related to self-management of kidney transplant recipients in the Core Collection of Web of Science and Scopus databases using COOC 12.8, R software, Microsoft Excel 2019, VOSviewer, and CiteSpace, with a focus on citation ranking, publication year, journal, country, organization, author, impact factor, and keywords.
Immunoglobulin-like receptor genotype-associated protection from cytomegalovirus infection after liver transplantation.
Transpl Immunol
December 2024
Organ Transplantation Center, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address:
Background: Cytomegalovirus (CMV) is a common clinical infection especially after organ transplantation and threaten the survival of recipients. Natural killer (NK) cells play an important role in the process of CMV infection. In this study, we want to explore that if the different of killer immunoglobulin-like receptors (KIRs) of NK cells could affect CMV infection.
View Article and Find Full Text PDFCeftazidime-avibactam for the treatment of febrile neutropenia in HSCT recipients and acute leukemia patients post induction chemotherapy.
Sci Rep
December 2024
American University of Beirut, Cairo Street, Riad El Solh, PO Box 11-0236/11D, Beirut, 1107 2020, Lebanon.
Febrile neutropenia is a major complication in patients with acute leukemia or those undergoing hematopoietic stem cell transplantation (HSCT). Understanding patient characteristics and susceptibility patterns in febrile neutropenia is essential for appropriate antimicrobial therapy. First-line agents should have Pseudomonas aeruginosa coverage, but with the increase in multi-drug resistant organisms, ceftazidime-avibactam has emerged as a new therapeutic option.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!